Private Label Cosmetics for the UK: Compliance Guide

Quick Answer: Private label cosmetics for the UK require more than a supplier’s product catalogue. For Great Britain, arrange a UK-established Responsible Person, a compliant formula and label, a Cosmetic Product Safety Report, a Product Information File and notification before market release. Northern Ireland follows a different route. A manufacturer can supply technical evidence, but outsourcing production does not automatically transfer the brand’s regulatory obligations.

By mooyam_admin (MOOYAM editorial team). Last reviewed: 9 October 2026. Cover: AI-generated editorial illustration.

What does UK private label compliance mean?

Private label describes a commercial arrangement, not an exemption. A ready-made formula sold under your brand still needs a market-specific review. The useful question is not whether a factory offers a “UK certificate”; it is whether the exact product, packaging, claims and supply chain can support the applicable route.

This guide focuses on the handover between a beauty brand and its OEM/ODM supplier. It separates legal requirements from recommended project controls. For the broader market-entry sequence, see how to sell cosmetics in the UK.

First, distinguish Great Britain from Northern Ireland

Great Britain means England, Scotland and Wales. Do not treat “UK launch” as one undifferentiated instruction to a supplier. The address on the label, notification route and arrangements for the Responsible Person depend on where the product will be placed on the market.

These distinctions are set out in the official GB enforcement guidance and Northern Ireland enforcement guidance. Special rules can apply to qualifying Northern Ireland goods; a mixed-market project should be reviewed for its actual supply chain.

Who is responsible: the brand, importer or manufacturer?

For GB, the legal role depends on the circumstances, including manufacture, import and distribution. A written appointment may be relevant; a purchase order alone is not a reliable substitute for confirming the role. Before ordering packaging, identify the named Responsible Person and get their acceptance of the product-review process.

A supplier should not be asked to promise that all responsibilities disappear once production is outsourced. The brand also controls information the factory may never see: website claims, retailer descriptions, intended users, launch territories and later changes to the product positioning.

A practical ownership map

• Manufacturer: supplies accurate formulation, manufacturing and available testing information for the agreed product.
• Brand owner: defines the intended product, markets, artwork and commercial claims, and coordinates the launch.
• Importer: establishes the relevant import arrangements and confirms whether it holds the Responsible Person role.
• Responsible Person: manages the applicable regulatory obligations, including the safety and documentation arrangements.
• Safety assessor: evaluates the evidence and prepares the safety assessment within the applicable qualification requirements.

This is a planning map, not a universal legal allocation. Confirm the contractual and regulatory roles for your own project before release.

What documents should a brand request before production?

The supplier’s dossier should describe the exact product being assessed. A generic certificate for the factory does not establish the safety of a particular formula in a particular package. Equally, a report for a different formula, fragrance or container should not be presented as though it covers the current product.

The official GB cosmetics guidance explains safety assessment, the PIF, manufacturing practice, notification, labelling and claims. Compliance with good manufacturing practice should not be confused with a blanket requirement to purchase an ISO 22716 certificate.

How should the brand manage the PIF and CPSR?

For GB, the PIF must be in English and retained for ten years after the last batch is placed on the market. Treat that as an ongoing information-management task, not a one-time folder upload. A product can outlive its original project manager, packaging designer or supplier contact.

Maintain one controlled product identifier linking the formula revision, package specification, safety report, label artwork and notification record. This identifier is a recommended internal control, not a government-issued approval number. It helps prevent an old attachment from being mistaken for current evidence.

For file structure and access arrangements, see UK Product Information File requirements. Do not describe the CPSR as a factory’s general certification; it concerns the safety assessment of the product.

A recommended private label launch sequence

1. Write the market brief. Identify GB, NI or both, intended users, product category, application method and proposed claims.
2. Confirm regulatory roles. Agree who will act as Responsible Person and how the importer and manufacturer exchange information.
3. Freeze the assessment version. Record the formula, fragrance, packaging and intended use to be reviewed.
4. Collect the technical package. Identify missing evidence early; ask the assessor what further information is needed rather than guessing a universal test panel.
5. Review the final artwork. Check the actual production proof, not only a designer’s initial layout. See UK cosmetic labelling requirements.
6. Complete the market-release checks. Reconcile the safety documentation, PIF and relevant notification with the finished product.
7. Maintain a post-launch process. Keep batch records, route complaints promptly and review changes before using revised materials.

There is no dependable universal number of days for this sequence. Timing depends on the available evidence, review findings, packaging changes and the appointed professionals. A supplier’s production lead time is not the same as a completed compliance lead time.

Common mistakes in UK private label projects

Ordering printed packaging before the regulatory review

A premature print run can make a small wording or address correction expensive. As a recommended workflow, release the artwork for printing only after the responsible reviewer has approved the specific version. Store that approval alongside the file rather than relying on a message remembered by one team member.

Changing the fragrance without reopening the dossier

A commercial change may affect the evidence needed for the finished product. Do not assume an existing assessment covers every supplier option. Ask the Responsible Person and assessor to review the change and identify what needs updating before manufacture or sale.

Turning manufacturing documents into marketing promises

A COA, SDS or factory quality record has a specific purpose. It should not be renamed a “UK government approval certificate.” Keep consumer-facing claims separate from internal evidence, and verify what each document actually supports.

Using one market’s arrangements everywhere

GB and NI routes differ. An EU notification does not automatically replace the GB route. For a cross-market project, use the EU/UK shared-product review to organize the questions without assuming identical obligations.

What can a cosmetic manufacturer provide?

An OEM/ODM manufacturer can help assemble the agreed technical handover: ingredient information, COA and SDS where relevant, manufacturing records, available stability and microbiological reports, packaging compatibility information and batch documentation. Availability and scope should be confirmed for the specific product and project; this list is not a claim that every report is automatically included.

Ask for a document register stating the product version, document owner, issue date and outstanding items. Separately agree confidentiality arrangements for detailed formulation information. A clean handover lets the appointed professionals assess real evidence rather than reconstructing the product from marketing copy.

FAQ

Does private label cosmetics status remove UK compliance requirements?

No. The commercial model does not remove the applicable product requirements. Review the actual formula, package, claims and destination.

Can an overseas factory automatically be the GB Responsible Person?

The GB role requires a UK-established Responsible Person. Confirm the lawful appointment and relevant supply-chain roles rather than assuming an overseas supplier holds that role.

Is an ISO certificate enough to launch a private label cosmetic?

No. Manufacturing evidence does not replace product safety documentation, the PIF, compliant labelling or the relevant notification.

Must the brand buy the same test package for every product?

Avoid a universal assumption. The safety assessor should identify the evidence needed for the specific formulation, use and packaging.

Should a new label or fragrance be checked after launch?

Yes. Use change control to identify whether the safety documentation, artwork, file or notification needs updating before the revised product is released.

Plan a documented manufacturer handover

MOOYAM provides cosmetic OEM/ODM manufacturing and technical documentation support for international beauty brands. Explore our OEM/ODM services or contact us with your destination market, product brief and documentation needs. Regulatory roles and independent review should be agreed as part of the project.

Regulatory requirements may change. Brands should verify current requirements with the relevant regulatory authority or qualified compliance professional before placing cosmetic products on the market. This article is general information, not product-specific legal advice.